Three Seasons Wealth, LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 2044495 SALT LAKE CITY, UT

Position in ROIV

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$818,728

New position

Shares Held

29,557

first reported quarter

Ownership

0.004%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Three Seasons Wealth, LLC holds $2,869,679 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	30,814	$1,676,589
2	SRRK	Scholar Rock Holding Corp	11,068	$608,740
3	RVMD	Revolution Medicines, Inc.	1,765	$330,549
4	SMMT	Summit Therapeutics Inc.	12,869	$187,501
5	SPRO	Spero Therapeutics, Inc.	30,000	$66,300

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$818,728	29,557	—	Shares	Sole	2026-05-05
No filing history on record for this holder in this stock.